Nektar Therapeutics (NKTR) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to loss of $0.22 per share a year ago.

Yasmeen Rahimi; Analyst; Piper Sandler & Co. Good day and thank you for standing by. Welcome to the Nektar Therapeutics fourth quarter 2024 financial results conference call. (Operator ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Nektar Therapeutics (NKTR – Research Report), with a price target of $7.00. The company’s shares closed ...

Oppenheimer upgraded Nektar (NKTR) to Outperform from Perform with a $6 price target Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor ...

Despite parting ways in 2016, Naomi Watts and her ex-husband Liev Schreiber have succeeded in creating an amicable, blended family. The former couple welcomed their first child, a boy, Sasha in ...

SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Nektar Therapeutics (NKTR) on Wednesday reported fourth-quarter earnings of $7.3 million. The San Francisco-based company said it had net income of 3 ...

(RTTNews) - Below are the earnings highlights for Nektar Therapeutics (NKTR): Earnings: $7.26 million in Q4 vs. -$42.08 million in the same period last year. EPS: $0.03 in Q4 vs. -$0.22 in the ...

Good day, and thank you for standing by. Welcome to the Nektar Therapeutics Fourth Quarter 2024 financial results conference call. At this time, all participants are in a listen-only mode.

Nektar Therapeutics (NKTR) reported its Q4 2024 earnings, surpassing analysts’ expectations with an earnings per share (EPS) of $0.03, compared to the forecasted loss of $0.16. The company’s ...

The firm’s content moderation approach raises concerns about regulation and advertisers. We sell different types of products and services to both investment professionals and individual ...

Yasmeen Rahimi; Analyst; Piper Sandler & Co. Good day and thank you for standing by. Welcome to the Nektar Therapeutics fourth quarter 2024 financial results conference call. (Operator Instructions) ...